The device was returned to biosense webster (bwi) for evaluation.The returned device's visual inspection and microscopic analysis were performed following bwi procedures.Visual analysis revealed a damage in the pebax and traces of blood.Microscopic analysis revealed a hole in the pebax exposing the internal components.The root cause of the damage could be related to improper handling; however, this cannot be conclusively determined.The issue reported by the customer was confirmed.The broken pebax was identified during the investigation of the sample received.A manufacturing record evaluation was performed for the finished device number 30965988l, and no internal action was found during the review.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
It was reported that a patient underwent a ventricular tachycardia (vt) cardiac ablation procedure with a thermocool® smart touch® sf uni-directional navigation catheter for which the biosense webster¿s product analysis lab (pal) observed a hole in the pebax exposing the internal components.Initially, it was reported that blood in catheter spring was observed during the procedure.A different catheter was used, and the issue was resolved.No adverse patient consequence was reported.The issue with blood found in the catheter was assessed as non mdr reportable.The potential risk that it could cause or contribute to a serious injury or death to the operator or patient was remote.The biosense webster, inc.Product analysis lab received the device for evaluation and per the evaluation completion on (b)(6) 2024, there was a hole in the pebax exposing the internal components.This was assessed as mdr reportable with an awareness date of 21-feb-2024.
|